CPT code 92081 represents a limited visual field examination in which a provider determines the extent of a patient's visual field for one or both eyes, interprets results, and prepares a report. This code matters nationally because visual field assessment is a core component of diagnosing and monitoring ocular conditions such as glaucoma, neurologic visual pathway disorders, and other vision-impairing diseases, and accurate coding ensures appropriate clinical documentation and claims processing. Key payers discussed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for limited visual field testing, common sites of service, and what CPT code 92081 specifically denotes compared with more comprehensive visual field services. The publication outlines typical billing considerations and benchmarks where available, highlights relevant policy elements that affect coverage and documentation, and provides guidance on how this code is used in clinical workflows. Data not provided in the input—such as specific payer coverage rules, reimbursement rates, ICD-10 pairings, and associated taxonomies—is noted as unavailable. The focus is national and intended for clinicians, coding professionals, and policy analysts who need a clear, authoritative reference on the scope and application of CPT code 92081.